Mologic
Latest round
- Series B
Last raised
- Apr 2018
Total raised
- $4.5M
Investors
- 2
About Mologic
Founded in 2003, Mologic Ltd. focuses on providing advanced diagnostic solutions., through its Global Access Diagnostics (GADx) division, specializes in developing lateral flow immunoassays offering services such as assay design, antibody engineering, validation, and clinical studies.In the most recent financial year 2023, Mologic Ltd.Following its acquisition in July 2021, Mologic Ltd. is positioned to enhance global diagnostics access in underprivileged regions, utilizing the GBP 30 million from the acquisition to facilitate decentralized research and development. The company aims to expand its operations into additional markets within the Global South, focusing on innovative product development and local manufacturing partnerships to meet regional health needs.
Who invested in Mologic
2 investors across 1 round
See all investors in Mologic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 23, 2018
Amount
$4.5M
Investors
Questions about Mologic
Who invested in Mologic?
Mologic has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mologic raised?
Mologic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mologic last raise money?
Mologic's most recent round on record is a Series B, in Apr 2018.
What does Mologic do?
Mologic is a biotechnology company.
Where is Mologic headquartered?
Mologic is headquartered in UK.
Which VCs invest in companies like Mologic?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Mologic's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Mologic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.